• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lipoprotein subfractions and particle size in end-stage renal disease.

作者信息

McCullough Peter A, Al-Ejel Fawaz, Maynard Robert C

出版信息

Clin J Am Soc Nephrol. 2011 Dec;6(12):2738-9. doi: 10.2215/CJN.10281011.

DOI:10.2215/CJN.10281011
PMID:22157706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3255361/
Abstract
摘要

相似文献

1
Lipoprotein subfractions and particle size in end-stage renal disease.终末期肾病中的脂蛋白亚组分与颗粒大小
Clin J Am Soc Nephrol. 2011 Dec;6(12):2738-9. doi: 10.2215/CJN.10281011.
2
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.非高密度脂蛋白胆固醇（non-HDL-C）作为终末期肾病患者心血管死亡的预测指标。
Kidney Int Suppl. 2003 May(84):S117-20. doi: 10.1046/j.1523-1755.63.s84.30.x.
3
LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.在终末期肾病患者中，与 LDL 胆固醇和风险分类相比，LDL 颗粒大小和数量。
J Nephrol. 2011 Nov-Dec;24(6):771-7. doi: 10.5301/JN.2011.6376.
4
Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.低密度脂蛋白胆固醇：与血液透析患者死亡率及住院率的关联
Blood Purif. 2005;23(2):134-40. doi: 10.1159/000083529. Epub 2005 Jan 21.
5
LDL cholesterol affects clinical outcomes in incident hemodialysis patients during the early stages of dialysis.低密度脂蛋白胆固醇在透析早期会影响新进入血液透析患者的临床结局。
Blood Purif. 2014;38(2):131-9. doi: 10.1159/000367803. Epub 2014 Nov 20.
6
Anti-inflammatory properties of high-density lipoprotein cholesterol in chronic hemodialysis patients: impact of intervention.高密度脂蛋白胆固醇在慢性血液透析患者中的抗炎特性：干预的影响。
J Ren Nutr. 2010 Nov;20(6):368-76. doi: 10.1053/j.jrn.2010.07.003. Epub 2010 Sep 15.
7
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者的透析方式与心血管死亡率比较
Adv Perit Dial. 2016;32:22-31.
8
Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.血清非高密度脂蛋白胆固醇（non-HDL-C）水平与慢性血液透析患者的心血管死亡率。
Clin Exp Nephrol. 2012 Oct;16(5):767-72. doi: 10.1007/s10157-012-0615-5. Epub 2012 Feb 29.
9
Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.非诺贝特和依折麦布单药治疗及联合用药对混合型高脂血症患者脂蛋白亚组分内胆固醇质量和低密度脂蛋白峰值粒径的影响。
Metabolism. 2008 Jun;57(6):796-801. doi: 10.1016/j.metabol.2008.01.026.
10
[Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].维持性血液透析和持续性非卧床腹膜透析的终末期肾衰竭儿童的脂蛋白（a）
Przegl Lek. 1997;54(5):320-3.

引用本文的文献

1
Association of high-density lipoprotein cholesterol with the estimated glomerular filtration rate in a community-based population.基于社区人群的高密度脂蛋白胆固醇与估算肾小球滤过率的关联
PLoS One. 2013 Nov 6;8(11):e79738. doi: 10.1371/journal.pone.0079738. eCollection 2013.

本文引用的文献

1
Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.新型脂蛋白亚组份和颗粒大小测量在维持性血液透析患者死亡率预测中的应用。
Clin J Am Soc Nephrol. 2011 Dec;6(12):2861-70. doi: 10.2215/CJN.03650411. Epub 2011 Oct 27.
2
LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.在终末期肾病患者中，与 LDL 胆固醇和风险分类相比，LDL 颗粒大小和数量。
J Nephrol. 2011 Nov-Dec;24(6):771-7. doi: 10.5301/JN.2011.6376.
3
Lipids in chronic kidney disease.慢性肾脏病中的脂质
J Ren Care. 2010 May;36 Suppl 1:27-33. doi: 10.1111/j.1755-6686.2010.00173.x.
4
Cardiovascular death in dialysis patients: lessons we can learn from AURORA.透析患者的心血管死亡：我们可以从 AURORA 中学到的教训。
Clin J Am Soc Nephrol. 2010 Feb;5(2):335-40. doi: 10.2215/CJN.06300909. Epub 2010 Jan 7.
5
Annual progression of coronary calcification in trials of preventive therapies: a systematic review.预防性治疗试验中冠状动脉钙化的年度进展：一项系统综述
Arch Intern Med. 2009 Dec 14;169(22):2064-70. doi: 10.1001/archinternmed.2009.382.
6
Comparability of methods for LDL subfraction determination: A systematic review.低密度脂蛋白亚组分测定方法的可比性：一项系统评价。
Atherosclerosis. 2009 Aug;205(2):342-8. doi: 10.1016/j.atherosclerosis.2008.12.011. Epub 2008 Dec 14.
7
Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same disease process.动脉粥样硬化性钙化与门克贝格动脉硬化的放大：同一疾病过程的不同表现
Adv Chronic Kidney Dis. 2008 Oct;15(4):396-412. doi: 10.1053/j.ackd.2008.07.009.
8
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.慢性肾脏病、心血管疾病过早患病率及其与短期死亡率的关系。
Am Heart J. 2008 Aug;156(2):277-83. doi: 10.1016/j.ahj.2008.02.024. Epub 2008 Jun 4.
9
Comparison of lipid measures and risk stratification among end-stage renal disease patients.
J Nephrol. 2007 Mar-Apr;20(2):212-8.
10
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.低密度脂蛋白颗粒数量和大小作为健康男性和女性冠状动脉疾病预测指标的价值：欧洲癌症与营养前瞻性调查诺福克前瞻性人群研究
J Am Coll Cardiol. 2007 Feb 6;49(5):547-53. doi: 10.1016/j.jacc.2006.09.043. Epub 2007 Jan 22.